CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

clinical study

ProNAi

ProNAi To Present Phase II Clinical Data For New Cancer Drug

ProNAi Therapeutics Inc., a developer of drugs that target cancer by interfering with cancer cells’ DNA, announced that data from its ongoing Phase II clinical study of its drug candidate PNT2258 will be presented at the 55th Annual Meeting of the American Society of Hematology in New Orleans Dec. 7-10.

WWJ Newsradio 950–11/10/2013

Esperion Gets Positive Results From New Study Of Cholesterol Drug

Esperion Therapeutics Inc. Friday announced “positive” results from a Phase 2a clinical study of its product candidate ETC-1002 in patients with high cholesterol and a history of bad reactions to existing statin drugs.

WWJ Newsradio 950–06/09/2013

AlphaCore Pharma art

AlphaCore Pharma Starts Clinical Trial Of New Heart Drug

The biopharmaceutical company AlphaCore Pharma Friday announced it had started a Phase 1 study of its drug candidate, ACP-501, for the treatment of high-risk atherosclerosis and serious lipid metabolism disorders.

WWJ Newsradio 950–04/01/2012

adeona

Adeona Gets Results From Alzheimer’s Product Candidate

Ann Arbor-based Adeona Pharmaceuticals Inc. late Thursday reported top-line results from its clinical study evaluating reaZin for the dietary management of Alzheimer’s disease and mild cognitive impairment.

04/17/2011

Wayne State Conducts Research Study For Fibroids

A Wayne State University obstetrician and gynecologist is conducting a clinical research study on alternative treatments — besides hysterectomy — for uterine fibroids. Jay Berman of the Wayne State University Physician Group is the only […]

09/13/2010